Based on current literature, it is not clear if multiple sclerosis (MS) patients are at increased risk to develop impaired glucose tolerance (IGT). Eighty-one MS patients and 45 healthy controls (HC) performed an oral glucose tolerance test. IGT was defined as a fasting glucose concentration of 6.1–6.9 mmol/l and two-hour post-load glucose of 7.8–11.1 mmol/l. The prevalence of impaired fasting glucose concentrations (17% vs 2%) and IGT (11% vs 0%) was higher in MS patients than HC. Accordingly, the areas under the glucose and insulin curves were higher in MS patients. The current study demonstrates an elevated IGT-prevalence in MS.
StuifbergenAK. Physical activity and perceived health status in persons with multiple sclerosis. J Neurosci Nurs1997; 29: 238–243.
2.
GrundySMHansenBSmithSCJr. Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol2004; 24: e19–e24.
3.
WensIDalgasUStenagerE. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis – a systematic review. Mult Scler2013; 19: 1556–1564.
4.
LavelaSLProhaskaTRFurnerS. Chronic diseases in male veterans with multiple sclerosis. Prev Chronic Dis2012; 9: E55.
5.
WarrenSWarrenKG. Multiple sclerosis and associated diseases: A relationship to diabetes mellitus. Can J Neurol Sci1981; 8: 35–39.
6.
HusseinWIReddySS. Prevalence of diabetes in patients with multiple sclerosis. Diabetes Care2006; 29: 1984–1985.
7.
KangJHChenYHLinHC. Comorbidities amongst patients with multiple sclerosis: A population-based controlled study. Eur J Neurol2010; 17: 1215–1219.
8.
FlemingSTBlakeJ. Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol1994; 47: 1127–1132.
SlawtaJNWilcoxARMcCubbinJA. Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis. Arch Phys Med Rehabil2003; 84: 1823–1830.
11.
SlawtaJNMcCubbinJAWilcoxAR. Coronary heart disease risk between active and inactive women with multiple sclerosis. Med Sci Sports Exerc2002; 34: 905–912.
12.
WhiteLJMcCoySCCastellanoV. Effect of resistance training on risk of coronary artery disease in women with multiple sclerosis. Scand J Clin Lab Invest2006; 66: 351–355.
13.
SternbergZLeungCSternbergD. The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients. CNS Neurol Disord Drug Targets2013; 12: 104–111.
14.
MählerASteinigerJBockM. Is metabolic flexibility altered in multiple sclerosis patients?PLoS One2012; 7: e43675.
15.
D’OrazioPBurnettRWFogh-AndersenN. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med2006; 44: 1486–1490.
16.
SternbergZLeungCSternbergD. Disease modifying therapies modulate cardiovascular risk factors in multiple sclerosis patients. Cardiovasc Ther. Epub ahead of print 1 October 2013. DOI: 10.1111/1755-5922.12049.
17.
BarnardKPevelerRCHoltRI. Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: Systematic review. Diabetes Care2013; 36: 3337–3345.
